ZG005 for Injection Clinical Trials
5 recruitingBiologic
Phase 25Phase 13
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd50 enrolled1 locationNCT06903377
Recruiting
Phase 1Phase 2
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd60 enrolled1 locationNCT06938880
Recruiting
Phase 1Phase 2
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
Lymphoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd60 enrolled1 locationNCT06883526
Recruiting
Phase 2
Study of ZG005 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd100 enrolled1 locationNCT06927687
Recruiting
Phase 2
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd90 enrolled1 locationNCT06558227